In 23-year-old wunderkind, anti-aging startups find champion, funding

April 11, 2018

Ron Leuty of the San Francisco Business Times featured 23-year old Laura Deming's Longevity Fund and its new accelerator, Age1, through which Deming hopes to create an ecosystem of companies working towards treatments for aging-related diseases.

 

Deming, a founding partner at Longevity Fund, started working in a lab at UCSF at age 12, helping to extend the lifespan of a type of worm through genetic engineering. She was accepted to MIT at age 14 to work on artificial organogenesis and bone aging. She dropped out her sophomore year to accept a $100,000 grant from the Thiel Fellowship, and Longevity Fund was born.

 

"There's really not a great community of aging and longevity founders right now," said Deming, who has raised $27 million for San Francisco-based Longevity Fund in two funds. "I'm excited about the ability for us to help them."

Please reload

 

SAN FRANCISCO
220 Montgomery St.

Ste. 1210
(415) 508-5901

sf@torchcommunications.com

BOSTON

50 Milk St.

16th Floor

(415) 994-0040

boston@torchcommunications.com

NEW YORK
81 Prospect St.
Brooklyn, NY 11201

nyc@torchcommunications.com

©2019 by Torch Communications.